Now, scientists have modified Salmonella bacteria to trigger a particularly powerful immune response against
human cancer cells implanted in mice, shrinking the tumors and — for the first time — preventing them from metastasizing.
Not exact matches
Shih, Wang and their colleagues tested fostamatinib's power to reduce tumor size in mice
implanted with
human ovarian
cancer cells that were resistant to paclitaxel.
By promoting DNA demethylation, high - dose vitamin C treatment induced stem
cells to mature, and also suppressed the growth of leukemia
cancer stem
cells from
human patients
implanted in mice.
Into the cerebral cortex of mice with these light - sensitive proteins, the team
implanted cancer cells from a
human pediatric cortical glioblastoma.
After confirming in mouse models that
cells from HER2 - positive breast
cancers became resistant to anti-HER2 treatment when
implanted into the brain but not into other tissues, the investigators found that HER3 is overexpressed in brain metastases of HER2 - positive breast
cancers from both mice and
human patients.
But because
cancer cells contain telomerase and also live forever, scientists worried that the newly immortal
cells would become malignant when
implanted in
humans.
We chose this model because 1) it more closely recapitulates features of
human pancreatic
cancer than do s.c. -
implanted tumors, 2) it can be used in immunocompetent mice to permit assessment of immune responses, and 3) the
cells grow in vivo with predictable kinetics (34).
Using RNA interference (RNAi), first author Richard Possemato targeted these genes in
human breast
cancer cells implanted in mice.